September 29, 2016 11:45 PM ET

Biotechnology

Company Overview of Juvaris BioTherapeutics, Inc.

Key Executives for Juvaris BioTherapeutics, Inc.

NameBoard RelationshipsTitleAge
Grant E. Pickering M.B.A.18 RelationshipsChief Executive Officer, President and Director48
Steven W. Dow Dvm, Ph.d.10 RelationshipsCo-Founder and Member of The Scientific Advisory Board--
Denny Liggitt DVM, Ph.D.10 RelationshipsCo-Founder and Member of Scientific Advisory Board--
Kimberlee H. Gonzaga CPANo RelationshipsChief Financial Officer--

Juvaris BioTherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Grant E. Pickering M.B.A. 18 RelationshipsJuvaris BioTherapeutics, Inc.48
Steven W. Dow Dvm, Ph.d. 10 RelationshipsJuvaris BioTherapeutics, Inc.--
Denny Liggitt DVM, Ph.D. 10 RelationshipsJuvaris BioTherapeutics, Inc.--
Thomas P. Monath M.D. 32 RelationshipsNewLink Genetics Corporation75
Lewis T. Williams M.D., Ph.D. 34 RelationshipsFive Prime Therapeutics, Inc.67
View All Board Members

Juvaris BioTherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
383.1K
Bonus
264.0K
Total Short Term Compensation
478.4K
Total Value of Options
32.9M
Compensation as of Fiscal Year
Juvaris BioTherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Factor Therapeutics Limited Appoints Melanie Farris AGIA as Company Secretary ,Effective September 29, 2016
September 28, 2016 10:30 PM ET
Medivation, Inc. Repays Outstanding Amounts Due in Connection with the Amended and Restated Credit Agreement, Dated as of October 23, 2015; Announces Board Changes
September 28, 2016 1:02 PM ET
Proteostasis Therapeutics Inc. Announces Board Appointments
September 28, 2016 11:30 AM ET
Bavarian Nordic A/S Appoints Dr. Christopher R. Heery as Chief Medical Officer
September 28, 2016 11:00 AM ET
China Regenerative Medicine International Limited Management Changes
September 28, 2016 9:34 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juvaris BioTherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.